Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125377432 | 12537743 | 2 | F | 20151203 | 20160629 | 20160707 | 20160707 | EXP | US-CELGENEUS-USA-2016067350 | CELGENE | 70.00 | YR | F | Y | 57.20000 | KG | 20160707 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125377432 | 12537743 | 1 | PS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | 125 MILLIGRAM/SQ. METER | Y | U | 6009530 | 21660 | 125 | MG/M**2 | UNKNOWN | ||||
| 125377432 | 12537743 | 2 | SS | PEGPH20 | HYALURONIDASE RECOMBINANT HUMAN | 1 | Intravenous drip | Y | U | 1-FIN-1734 | 0 | 3 | UG/KG | UNKNOWN | |||||
| 125377432 | 12537743 | 3 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | Y | U | 6H11503A | 55974 | 1000 | MG/M**2 | UNKNOWN | |||||
| 125377432 | 12537743 | 4 | C | CARDURA | DOXAZOSIN MESYLATE | 1 | Unknown | 3 MICROGRAM/KILOGRAM | 0 | UNKNOWN | |||||||||
| 125377432 | 12537743 | 5 | C | Hydromorphone | HYDROMORPHONE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125377432 | 12537743 | 6 | C | COLACE | DOCUSATE SODIUM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125377432 | 12537743 | 7 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125377432 | 12537743 | 8 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125377432 | 12537743 | 9 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125377432 | 12537743 | 10 | C | DURAGESIC | FENTANYL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125377432 | 12537743 | 11 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125377432 | 12537743 | 12 | C | CLONIDINE. | CLONIDINE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125377432 | 12537743 | 13 | C | AVAPRO | IRBESARTAN | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125377432 | 12537743 | 1 | Pancreatic carcinoma |
| 125377432 | 12537743 | 2 | Pancreatic carcinoma |
| 125377432 | 12537743 | 3 | Pancreatic carcinoma |
| 125377432 | 12537743 | 4 | Product used for unknown indication |
| 125377432 | 12537743 | 5 | Product used for unknown indication |
| 125377432 | 12537743 | 6 | Product used for unknown indication |
| 125377432 | 12537743 | 7 | Product used for unknown indication |
| 125377432 | 12537743 | 8 | Product used for unknown indication |
| 125377432 | 12537743 | 9 | Product used for unknown indication |
| 125377432 | 12537743 | 10 | Product used for unknown indication |
| 125377432 | 12537743 | 11 | Product used for unknown indication |
| 125377432 | 12537743 | 12 | Product used for unknown indication |
| 125377432 | 12537743 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125377432 | 12537743 | OT |
| 125377432 | 12537743 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125377432 | 12537743 | Anaemia | |
| 125377432 | 12537743 | Electrolyte imbalance | |
| 125377432 | 12537743 | Pancytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125377432 | 12537743 | 1 | 20151125 | 20151201 | 0 | |
| 125377432 | 12537743 | 2 | 20151124 | 20151201 | 0 | |
| 125377432 | 12537743 | 3 | 20151125 | 20151201 | 0 |